Beware off-label claims by manufacturers, experts warn 28 Mar 2012 0 comments Sydney experts have weighed into the debate on off-label prescribing, arguing for improved monitoring, particularly of pharmaceutical companies who plug off-label use of their products.
PBAC recommends removing liver biopsy obstacle to hepatitis B treatment 24 Aug 2011 0 comments Liver biopsy should no longer be a mandatory requirement for patients with Hepatitis B to access antivirals and interferon medications, the Pharmaceutical Benefits Advisory Committee recommends.
Rebate means test threatens regional specialists 24 Aug 2011 0 comments Hospitals in regional areas may lose proceduralists as a result of changes to the private health insurance rebate.
Medical journals still haunted by ghostwriters 10 Aug 2011 0 comments Ghostwriting in medical journals is equivalent to fraud and should be punished as such, argue lawyers.
